Back to Explorer

21CFR516.23

§ 516.23 Timing of requests for MUMS-drug designation.

Regulation Text

A sponsor may request MUMS-drug designation at any time in the drug development process prior to the submission of an application for either conditional approval or approval of the MUMS drug for which designation is being requested.

Authority

21 U.S.C. 360ccc-1,360ccc-2,371.

View in Graph Explorer
21CFR516.23 — § 516.23 Timing of requests for MUMS-drug designation. | CFR Explorer | BioRegHub